A new systematic review and meta-analysis is set to examine one of the most complex questions in modern public health:...

A new study describes a high-throughput strategy for engineering bispecific antibodies that could help macrophages destroy malignant B cells more...

WASHINGTON — A combination of two immunotherapy drugs produced substantially higher rates of tumor eradication when added to chemotherapy before...

Anti-angiogenic drugs were expected to starve tumors by cutting off their blood supply. Yet many cancers eventually adapt, finding alternative...

DNA repair has traditionally been viewed as a process centred in the nucleus, where the genome is stored and monitored....

Cancer of Unknown Primary is one of oncology’s most frustrating diagnoses: a patient has metastatic cancer, yet conventional tests cannot...

A negative BRCA1 or BRCA2 test does not necessarily place a woman at the same breast cancer risk as the...

Liquid biopsy is emerging as a potential way to detect and monitor cancer without repeatedly removing tissue from a tumor....

A new clinical trial is opening a potentially important chapter in the treatment of primary plasma cell leukemia, a rare...

Memorial Sloan Kettering Cancer Center researchers have reported a series of findings that could reshape treatment strategies across oncology, from...